ABSTRACT:
The present work involves the formulation of sublingual films of Cilnidipine, a BCS Class II drug, faces a major problem due to its bioavailability of 13% in oral dosage form. To increase solubility and bioavailability, nanocrystals were prepared using antisolvent crystallization technique. Solubility of prepared Cilnidipine crystals were studied then subjected for FTIR, DSC, SEM, XRD and In-vitro dissolution studies for characterization and evaluation. This reveals a significant increase in drug dissolution and solubility with a decrease in particle size compared to pure Cilnidipine. The crystals also showed compatibility with the drug and excipients, with smaller crystals. Powder X-ray diffraction revealed decreased intensity of peaks compared to pure drug. Crystals prepared using ethanol as a solvent under ultrasonication (Probe) showed the highest solubility and dissolution rate at 60 minutes, with better results in drug content and compared to pure drug. Anti-solvent crystallization method was successful in formulating cilnidipine crystals with high dissolution rates to eliminate solubility-related bioavailability issues. Further Cilnidipine crystals were formulated into Fast Dissolving Sublingual Films by solvent-casting method. The fast-dissolving films of Cilnidipine were prepared using HPMC E5, HPMC E15 and HPMC E50 as film forming polymers and PEG400 was used as plasticizer. Films were evaluated for physical characteristic such as uniformity of weight, thickness, folding endurance, drug content uniformity, surface pH, tensile strength. Fourier transform infrared spectroscopy and In- vitro release studies. All films were found to be satisfactory when evaluated for thickness, weight uniformity, folding endurance and drug content. The optimized formulation F2 showed satisfactory pH and drug content (93.7%). The in-vitro drug release in optimized formulation F2 was found to more than 95.55% within 10 min and satisfactory stability. Fast dissolving films of Cilnidipine crystals can be considered suitable for clinical use in the treatment of Hypertension and hypertensive associated vascular disorders where a quicker onset of action is desirable along with the convenience of administration.
Cite this article:
Jyothi B, Yogananda R, Uma M. Development and Evaluation of Fast Dissolving Sublingual of Cilnidipine Nanocrystals for Enhanced Solubility, Dissolution and Bioavailability. Asian Journal of Pharmacy and Technology. 2025; 15(1):25-3. doi: 10.52711/2231-5713.2025.00005
Cite(Electronic):
Jyothi B, Yogananda R, Uma M. Development and Evaluation of Fast Dissolving Sublingual of Cilnidipine Nanocrystals for Enhanced Solubility, Dissolution and Bioavailability. Asian Journal of Pharmacy and Technology. 2025; 15(1):25-3. doi: 10.52711/2231-5713.2025.00005 Available on: https://ajptonline.com/AbstractView.aspx?PID=2025-15-1-5
REFERENCES:
1. Bhura N, Sanghvi K, Patel U, Parmar B. A review on fast dissolving film. The International Journal of Pharmaceutical Research and Bio-Science. 2012; 1(3): 279-285.
2. Narang N, Sharma J. Sublingual mucosa as a route for systemic drug delivery. Int J Pharm Pharm Sci. 2011; 3(2): 18-22.
3. Saha PU, Verma SU, Das PS. Sublingual drug delivery: an indication of potential alternative route. International Journal of Current Pharmaceutical Research.
4. Sharma A K. Development and evaluation cilnidipine fast dissolving tablet by using is apghula husk as natural super disintegrant. Tablet. 2019; 11(1); 01-11.
5. Thorat V P, Mahaparale P R and Gonjari I D. Fast Dissolving Drug Delivery System of Cilnidipine using Gelucire 50/13. Research J. Pharm. and Tech. 2019; 12(5):2185-2188.
6. Park MW, Yeo SD. Antisolvent crystallization of carbamazepine from organic solutions. Chemical Engineering Research and Design. 2012 Dec 1;90(12):2202-8.
7. Kaza R, Yalaravathi PR, Ravoru N. Design and Characterization of Fast Dissolving Films of Valsartan. Turk J Pharm Sci. 2014; 11(2):175-84.
8. Chethan Patel DN, Shrenath A. A solubility enhancement of aceclofenac by new crystallization technique. Asian Journal of Pharmaceutical and Clinical Research. 2022;15(2):113-118.
9. Maghsoodi M, Shahi F. Combined Use of Polymers and Porous Materials to Enhance Cinnarizine Dissolution. Pharmaceutical Sciences. 2019;25(4):331-337.
10. Ammar HO, Ghorab M, Kamel R, Salama AH. A trial for the design and optimization of pH-sensitive microparticles for intestinal delivery of cinnarizine. Drug Delivery and Translational Research. 2016;6(3):195-209.
11. Singh H, Kumar M, Gupta S, Sekharan TR, Tamilvanan S. Influence of hydrophilic polymers addition into cinnarizine-β-cyclodextrin complexes on drug solubility, drug liberation behaviour and drug permeability. Polymer Bulletin. 2018; 75(7): 2987-3009.
12. Shahba AA, Ahmed AR, Alanazi FK, Mohsin K, Abdel-Rahman SI. Multi-layer self-nanoemulsifying pellets: An innovative drug delivery system for the poorly water-soluble drug cinnarizine. AAPS Pharm SciTech. 2018; 19(5): 2087-2102.
13. Janrao KK, Gadhave MV, Banerjee SK, Gaikwad DD. Preparation and Characterization of Spherical Crystals of Simvastatin to enhance the Solubility and Micrometric Properties. Asian Journal of Pharmaceutical Research and Development. 2014; 2(2): 96-104.
14. Mohapatra S, Sahoo SK, Kar RK. Application of central composite design for optimization of effervescent floating Tablets Using Hydrophilic Polymers. Asian Journal of Pharmaceutical and Clinical Research. 2015; 8(1): 293-298.
15. Modh.N H, Mahe.M, Pan H. Formulation and evaluation of sublingual film of prazocin HCl. Journal of Emerging Technologies and Innovative Research 2021;8(5):596-607.
16. Kaur P, Kumar V. Formulation development and evaluation of fast dissolving bioadhesive sublingual film of sumatriptan. World Journal of Pharmaceutical Research. 2017; 6(14): 385-410.
17. Aher SS, Sangale VD, Saudagr RB. Formulation and evaluation of sublingual film of Hydralazine Hydrochloride. Research Journal of Pharmacy and Technology. 2016; 9(10): 1681-90.
18. Harshitha KN, Shruthi BN, ST B. Design and Characterization of Fast Dissolving Films of Cilnidipine Solid Dispersions. 2018; 8(14): 207-218.
19. Velrajan G, Sambasivarao P, Kannan S. Design and evaluation of moxifloxacin periodontal films. World Journal of Pharmaceutical Research. 2014; 3(3): 4208- 4216.
20. Wadetwar RN, Ali F, Kanojiya PR. Formulation and Evaluation of Fast Dissolving Sublingual Film of Paroxetine Hydrochloride for Treatment of Depression. Asian Journal of Pharmaceutical Clinical Research. 2019; 12(10): 126-32.